Your browser doesn't support javascript.
loading
Bridging communities in the field of nanomedicine.
Halamoda-Kenzaoui, Blanka; Baconnier, Simon; Bastogne, Thierry; Bazile, Didier; Boisseau, Patrick; Borchard, Gerrit; Borgos, Sven Even; Calzolai, Luigi; Cederbrant, Karin; Di Felice, Gabriella; Di Francesco, Tiziana; Dobrovolskaia, Marina A; Gaspar, Rogério; Gracia, Belén; Hackley, Vincent A; Leyens, Lada; Liptrott, Neill; Park, Margriet; Patri, Anil; Roebben, Gert; Roesslein, Matthias; Thürmer, René; Urbán, Patricia; Zuang, Valérie; Bremer-Hoffmann, Susanne.
Afiliação
  • Halamoda-Kenzaoui B; European Commission Joint Research Centre (JRC), Ispra, Italy.
  • Baconnier S; Université Grenoble Alpes, CEA LETI MlNATEC Campus, Grenoble, France.
  • Bastogne T; Université de Lorraine, CNRS, CRAN, INRIA BIGS, Nancy, France.
  • Bazile D; CMC External Innovation, Sanofi, Gentilly, France.
  • Boisseau P; Université Grenoble Alpes, CEA LETI MlNATEC Campus, Grenoble, France.
  • Borchard G; Université de Genève, Ecole de Pharmacie Genève-Lausanne, Genève, Switzerland.
  • Borgos SE; SINTEF Industry, Trondheim, Norway.
  • Calzolai L; European Commission Joint Research Centre (JRC), Ispra, Italy.
  • Cederbrant K; Swedish Toxicology Sciences Research Center (Swetox), Södertälje, Sweden.
  • Di Felice G; National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Roma, Italy.
  • Di Francesco T; Université de Genève, Ecole de Pharmacie Genève-Lausanne, Genève, Switzerland.
  • Dobrovolskaia MA; Nanotechnology Characterization Laboratory (NCL), Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Sponsored By the National Cancer Institute, Frederick, USA.
  • Gaspar R; Faculty of Pharmacy and Institute for Bioengineering and Biosciences of the University of Lisbon, Lisboa Portugal.
  • Gracia B; Department of Medicines for Human Use, Agencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
  • Hackley VA; National Institute of Standards and Technology (NIST), Materials Measurement Science Division, Gaithersburg, USA.
  • Leyens L; Swissmedic, Swiss Agency for Therapeutic Products, Bern, Switzerland.
  • Liptrott N; Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, The University of Liverpool, Liverpool, United Kingdom.
  • Park M; RIVM- National Institute for Public Health and the Environment, Bilthoven, Netherlands.
  • Patri A; U.S. Food & Drug Administration (FDA), Nanotechnology Core Facility, Jefferson, USA.
  • Roebben G; European Commission Joint Research Centre (JRC), Geel, Belgium.
  • Roesslein M; Empa - Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland.
  • Thürmer R; BfArM - Federal Institute for Drugs and Medical Devices, Bonn, Germany.
  • Urbán P; European Commission Joint Research Centre (JRC), Ispra, Italy.
  • Zuang V; European Commission Joint Research Centre (JRC), Ispra, Italy.
  • Bremer-Hoffmann S; European Commission Joint Research Centre (JRC), Ispra, Italy. Electronic address: susanne.bremer-hoffmann@ec.europa.eu.
Regul Toxicol Pharmacol ; 106: 187-196, 2019 Aug.
Article em En | MEDLINE | ID: mdl-31051191
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanomedicina Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanomedicina Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália